Belx Bio-Pharmaceutical Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
Belx Bio-Pharmaceutical General Information
Description
Developer of botanical drugs intended for the treatment of tumors and chronic liver diseases. The company's drugs have improved therapeutic outcomes and fewer side effects can be used simultaneously in combination with existing cancer drugs, it manufactures botanical drugs on par with pharmaceutical companies and follows a thorough six-step process, which also includes clinical trials and producing plant-based pharmaceutical interventions, enabling medical practitioners to improve treatment efficacy and the quality of life for cancer patients.
Contact Information
Website
www.belxbiopharma.comCorporate Office
- Rm. 536, Bldg. 52, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu
- 31040, Taiwan, ROC
- Hsinchu County
- Taiwan
Corporate Office
- Rm. 536, Bldg. 52, 195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu
- 31040, Taiwan, ROC
- Hsinchu County
- Taiwan
Belx Bio-Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 4. Later Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 3. Grant | 01-Nov-2019 | Completed | Clinical Trials - Phase 1 | |||
| 2. Grant | 01-Sep-2018 | Completed | Clinical Trials - Phase 1 | |||
| 1. Grant | 01-Jan-2018 | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Belx Bio-Pharmaceutical Patents
Belx Bio-Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022205137-A1 | Polymeric proanthocyanidin composition and application thereof | Inactive | 31-Mar-2021 | ||
| AU-2022202161-A1 | Polymeric proathocyanidin composition and application thereof | Active | 31-Mar-2021 | ||
| AU-2022202161-B2 | Polymeric proathocyanidin composition and application thereof | Inactive | 31-Mar-2021 | ||
| CA-3153407-A1 | Polymeric proathocyanidin composition and application thereof | Active | 31-Mar-2021 | ||
| EP-4066828-A1 | Polymeric proathocyanidin composition and application thereof | Inactive | 31-Mar-2021 | A61K31/765 |
Belx Bio-Pharmaceutical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ITO Invest Taipei | Government | Minority | ||
| Ministry of Economic Affairs | Government | Minority | ||
| Innovation Industrial Technology Transfer | Corporate Venture Capital | Minority | ||
| Silicon Valley Advantage | Accelerator/Incubator |
Belx Bio-Pharmaceutical FAQs
-
When was Belx Bio-Pharmaceutical founded?
Belx Bio-Pharmaceutical was founded in 2016.
-
Where is Belx Bio-Pharmaceutical headquartered?
Belx Bio-Pharmaceutical is headquartered in Hsinchu County, Taiwan.
-
What industry is Belx Bio-Pharmaceutical in?
Belx Bio-Pharmaceutical’s primary industry is Drug Discovery.
-
Is Belx Bio-Pharmaceutical a private or public company?
Belx Bio-Pharmaceutical is a Private company.
-
What is Belx Bio-Pharmaceutical’s current revenue?
The current revenue for Belx Bio-Pharmaceutical is .
-
Who are Belx Bio-Pharmaceutical’s investors?
ITO Invest Taipei, Ministry of Economic Affairs, Innovation Industrial Technology Transfer, and Silicon Valley Advantage have invested in Belx Bio-Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process